Literature DB >> 8674022

Assessment of prostate carcinoma in core needle biopsy--definition of minimal criteria for the diagnosis of cancer in biopsy material.

F Algaba1, J I Epstein, H C Aldape, G M Farrow, A Lopez-Beltran, J Maksem, R E Orozco, A Pacelli, T M Pisansky, I Trias.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8674022     DOI: 10.1002/(SICI)1097-0142(19960715)78:2<376::AID-CNCR32>3.0.CO;2-R

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  11 in total

Review 1.  [Chemoprevention of prostate cancer].

Authors:  B Djavan; I Thompson; M S Michel; M Waldert; C Seitz
Journal:  Urologe A       Date:  2004-05       Impact factor: 0.639

Review 2.  Gleason 6 Prostate Cancer: Translating Biology into Population Health.

Authors:  Scott E Eggener; Ketan Badani; Daniel A Barocas; Glen W Barrisford; Jed-Sian Cheng; Arnold I Chin; Anthony Corcoran; Jonathan I Epstein; Arvin K George; Gopal N Gupta; Matthew H Hayn; Eric C Kauffman; Brian Lane; Michael A Liss; Moben Mirza; Todd M Morgan; Kelvin Moses; Kenneth G Nepple; Mark A Preston; Soroush Rais-Bahrami; Matthew J Resnick; M Minhaj Siddiqui; Jonathan Silberstein; Eric A Singer; Geoffrey A Sonn; Preston Sprenkle; Kelly L Stratton; Jennifer Taylor; Jeffrey Tomaszewski; Matt Tollefson; Andrew Vickers; Wesley M White; William T Lowrance
Journal:  J Urol       Date:  2015-04-04       Impact factor: 7.450

Review 3.  Diagnosis of adenocarcinoma in prostate needle biopsy tissue.

Authors:  P A Humphrey
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

4.  Minimal focus of adenocarcinoma on prostate biopsy: clinicopathological correlations.

Authors:  X Leroy; S Aubert; A Villers; C Ballereau; D Augusto; B Gosselin
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

5.  Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?

Authors:  Olivio F Donati; Sung Il Jung; Hebert Alberto Vargas; David H Gultekin; Junting Zheng; Chaya S Moskowitz; Hedvig Hricak; Michael J Zelefsky; Oguz Akin
Journal:  Radiology       Date:  2013-03-12       Impact factor: 11.105

Review 6.  What's new in the field of prostate cancer chemoprevention?

Authors:  Kanwaljit Mahal; Javier Hernandez; Joseph W Basler; Ian M Thompson
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

Review 7.  Single foci prostate cancer: current diagnosis and management.

Authors:  Ioannis Efthimiou; Konstadinos Skrepetis; Elefteria Bournia
Journal:  Curr Urol       Date:  2013-07-28

8.  Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.

Authors:  Jung Wook Park; John K Lee; John W Phillips; Patrick Huang; Donghui Cheng; Jiaoti Huang; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-04       Impact factor: 11.205

Review 9.  What's new in the field of prostate cancer chemoprevention?

Authors:  Kanwaljit Mahal; Javier Hernandez; Joseph W Basler; Ian M Thompson
Journal:  Curr Urol Rep       Date:  2005-05       Impact factor: 2.862

10.  Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance-promising for molecular staging of prostate cancers.

Authors:  Magdalena Bryś; Monika Migdalska-Sęk; Dorota Pastuszak-Lewandoska; Ewa Forma; Karolina Czarnecka; Daria Domańska; Ewa Nawrot; Jacek Wilkosz; Waldemar Różański; Ewa Brzeziańska
Journal:  Med Oncol       Date:  2013-01-04       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.